Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$204.46 USD
+1.69 (0.83%)
Updated Dec 8, 2023 04:00 PM ET
After-Market: $204.47 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Detailed Estimates
Estimates
Exp Earnings Date | 2/28/24 |
---|---|
Current Quarter | 2.40 |
EPS Last Quarter | 2.72 |
Last EPS Surprise | 15.74% |
ABR | 1.62 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 10.56 |
Next Year | 10.94 |
EPS (TTM) | 11.17 |
P/E (F1) | 19.36 |
Sales Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 997.98M | 1.02B | 4.10B | 4.26B |
# of Estimates | 6 | 5 | 6 | 6 |
High Estimate | 1.03B | 1.05B | 4.11B | 4.31B |
Low Estimate | 976.82M | 1.01B | 4.09B | 4.22B |
Year ago Sales | 1.10B | 1.03B | 3.98B | 4.10B |
Year over Year Growth Est. | -9.26% | -0.53% | 3.17% | 3.85% |
Earnings Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.40 | 2.41 | 10.56 | 10.94 |
# of Estimates | 8 | 5 | 9 | 9 |
Most Recent Consensus | 2.31 | 2.32 | 10.50 | 10.83 |
High Estimate | 2.48 | 2.62 | 10.65 | 11.10 |
Low Estimate | 2.25 | 2.31 | 10.44 | 10.80 |
Year ago EPS | 2.98 | 2.78 | 11.12 | 10.56 |
Year over Year Growth Est. | -19.46% | -13.31% | -5.04% | 3.62% |
Agreement - Estimate Revisions
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 4 | 0 |
Up Last 60 Days | 0 | 0 | 5 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 5 | 2 | 2 | 7 |
Down Last 60 Days | 6 | 3 | 2 | 9 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | 2.40 | 2.41 | 10.56 | 10.94 |
7 Days Ago | 2.40 | 2.41 | 10.56 | 10.94 |
30 Days Ago | 2.58 | 2.46 | 10.50 | 11.11 |
60 Days Ago | 2.64 | 2.47 | 10.49 | 11.22 |
90 Days Ago | 2.66 | 2.59 | 10.50 | 11.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.40 | 2.44 | 10.57 | 10.94 |
Zacks Consensus Estimate | 2.40 | 2.41 | 10.56 | 10.94 |
Earnings ESP | 0.00% | 1.08% | 0.10% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.72 | 2.69 | 2.78 | 2.98 | NA |
Estimate | 2.35 | 2.63 | 2.59 | 2.75 | NA |
Difference | 0.37 | 0.06 | 0.19 | 0.23 | 0.21 |
Surprise | 15.74% | 2.28% | 7.34% | 8.36% | 8.43% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more